DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/37adf0/eli_lilly_co_p) has announced the addition of the "Eli Lilly & Co.: PharmaVitae Profile" company profile to their offering.
Introduction
This analysis examines the historical and forecast performance for Eli Lilly in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
- Benchmark Eli Lilly's performance against key rivals in the prescription pharmaceutical sector
- Assess the commercial outlook for key new launch products Effient and Bydureon
- Evaluate Eli Lilly's ability to overcome the adverse impact of patent expiry for Zyprexa, Cymbalta and other key franchises over the period 2011-14
Key Topics Covered:
Chapter 1 About this profile
Chapter 2 Executive summary Chapter 3 Quarterly news update
Chapter 4 Company introduction
Chapter 5 Company sales
Chapter 6 Company financials
Chapter 7 Key products and competitors
Chapter 8 Appendix
Companies Mentioned:
- Abbott Laboratories
- ACS Motion Control Ltd
- Alkermes Inc
- Amylin Pharmaceuticals Inc
- AstraZeneca PLC
- Automatic Data Processing, Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Cephalon
- Chugai Pharmaceutical Co. Ltd
- Citizen Electronics Company Limited
- Daiichi Sankyo, Ltd.
- Eli Lilly and Company
- GlaxoSmithKline Plc
- Impax Laboratories, Inc.
- IMS Health
- Johnson & Johnson
- Merck & Co., Inc.
- NICE Systems Ltd
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc
- Pivotal Corporation
For more information visit http://www.researchandmarkets.com/research/37adf0/eli_lilly_co_p
Source: Datamonitor
CONTACT:
Research and Markets
Laura Wood, Senior Manager
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
KEYWORDS:
INDUSTRY KEYWORDS: Health Pharmaceutical
MEDIA:
| Logo |